WordNet

a silvery ductile metallic element found primarily in bauxite (同)aluminium, Al, atomic number 13
defective bone development; usually attributable to renal disease or to disturbances in calcium and phosphorus metabolism

PrepTutorEJDIC

《米》アルミニウム(金属元素の一つ;化学記号は『Al』;《英》alminium)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 腎性骨異栄養症の骨生検および診断 bone biopsy and the diagnosis of renal osteodystrophy
2. 慢性腎臓病におけるアルミニウム毒性 aluminum toxicity in chronic kidney disease
3. 小児における、慢性腎臓病に伴う骨ミネラル代謝異常（CKD-MBD） pediatric chronic kidney disease mineral and bone disorder ckd mbd
4. 腎移植後の副甲状腺とミネラル代謝 parathyroid and mineral metabolism after renal transplantation
5. 慢性腎疾患における高リン血症の治療 treatment of hyperphosphatemia in chronic kidney disease

English Journal

Pre-operative fibrous osteodystrophy and severe, refractory, post-operative hypocalcemia following parathyroidectomy in a dog.

Reinhart JM1, Nuth EK1, Byers CG1, Thoesen M1, Armbrust LJ1, Biller DS1, Harkin KR1.
The Canadian veterinary journal = La revue veterinaire canadienne.Can Vet J.2015 Aug;56(8):867-71.
in

English, FrenchOstéodystrophie fibreuse préopératoire et hypocalcémie grave, réfractaire postopératoire après une parathyroïdectomie chez un chien. Un chien âgé de 13 ans a manifesté une ostéopénie radiographique dramatique conforme à une ostéodystrophie fibreuse secondaire à

PMID 26246635

When, how, and why a bone biopsy should be performed in patients with chronic kidney disease.

Torres PU1, Bover J2, Mazzaferro S3, de Vernejoul MC4, Cohen-Solal M4.
Seminars in nephrology.Semin Nephrol.2014 Nov;34(6):612-25. doi: 10.1016/j.semnephrol.2014.09.004.
In chronic kidney disease the excessive production of parathyroid hormone increases the bone resorption rate and leads to histologic bone signs of secondary hyperparathyroidism. However, in other situations, the initial increase in parathyroid hormone and bone remodeling may be slowed down excessive
PMID 25498380

Reducing the risk of re-fracture in the dialysis population: is it time to consider therapy with PTH analogues?

Jamal SA, Hodsman AB.
Seminars in dialysis.Semin Dial.2011 Jan-Feb;24(1):12-5. doi: 10.1111/j.1525-139X.2010.00817.x. Epub 2011 Feb 7.
Dialysis patients are at high risk for fracture, with published rates in excess of a 20% probability of fracture over the next 10 years of dialysis. Unfortunately, there is no accepted methodology for quantifying this risk in advance of the first fracture; conventional bone densitometry performs unr
PMID 21299630